Probiotics Boost Depression Treatment in 2026 Study
The 2026 PRODG trial, a randomized, double-blind, placebo-controlled study from India, found that adding specific probiotics to standard antidepressant …
The 2026 PRODG trial, a randomized, double-blind, placebo-controlled study from India, found that adding specific probiotics to standard antidepressant …
Electroacupuncture and Vitamin D: Emerging Avenues for IBS-C Management Irritable Bowel Syndrome with predominant constipation (IBS-C) presents a comple…
Introduction Research on the gut-brain axis continues to clarify how the gut microbiome communicates with the brain to influence mood
Irritable Bowel Syndrome Management: A Systemic View Irritable bowel syndrome (IBS) is often viewed as a disorder confined to the gut
For the 10% of children and adolescents living with irritable bowel syndrome with constipation (IBS-C), effective treatment must address two core challe…
The Gut-Brain Connection: A Two-Way Street in Mental Health The gut and brain are in constant communication through the gut-brain axis
Escitalopram Improves Gut and Mood Symptoms by Altering Specific Microbes For elderly patients with disorders of gut-brain interaction (DGBIs), a common…
New Evidence for IBS-C Treatment: From Children’s Medication to Adult Pelvic Floor Care Linaclotide, a prescription medication, has received U.S
Introduction A new national consensus guideline from the Israeli Gastroenterology Association provides the most specific standards to date for diagnosin…
New Linaclotide Data and Pelvic Floor Consensus Reframe IBS-C Approach Irritable Bowel Syndrome with constipation (IBS-C) remains a challenging disorder…
FDA Approves First Pediatric IBS-C Drug While Guidelines Urge Broader Assessment The treatment landscape for irritable bowel syndrome with constipation …
Introduction A 2026 review from Qingdao University proposes that imbalances in iron metabolism, both in the brain and body, are a significant factor in …